The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Wu, Chih Cheng ^a,c,d   Huang, Po Hsun ^b,d   Lai, Chao Lun ^a,c   Leu, Hsin Bang ^a,b,d   Chen, Jaw Wen ^b,d   Lin, Shing Jong ^b,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CD34 SELECTION; CELL ADHESION; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMODIALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESTENOSIS; RISK FACTOR; SENESCENCE; VASCULAR ACCESS; VASCULAR SURGERY; AGED; ANGIOPLASTY; CELL CULTURE; CELL PROLIFERATION; CENTRAL VENOUS CATHETER; CYTOLOGY; GRAFT OCCLUSION; METABOLISM; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY;

AGED; ANGIOPLASTY; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FLOW CYTOMETRY; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; VASCULAR ACCESS DEVICES;

EID: 84903549062     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101058     Document Type: Article

References (32)

1. Roy-Chaudhury P, Sukhatme VP, Cheung AK (2006) Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112-1127.
2. Bittl JA (2010) Catheter interventions for hemodialysis fistulas and grafts. J Am Coll Cardiol Intv 3: 1-11.
3. Inoue T, Croce K, Morooka T, Sakuma M, Node K, et al. (2011) Vascular Inflammation and Repair Implications for Re-Endothelialization, Restenosis, and Stent Thrombosis. J Am Coll Cardiol Intv 4: 1057-1066.
4. Werner N, Priller J, Laufs U, Endres M, Böhm M, et al. (2002) Bone Marrow-Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation. Arterioscler Thromb Vasc Biol 22: 1567-1572.
5. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, et al. (2003) Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. N Engl J Med 348: 593-600. (Pubitemid 36204953)
6. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, et al. (2004) Uremia causes endothelial progenitor cell deficiency. Kidney Int 66: 641-646. (Pubitemid 38982006)
7. Maruyama S, Taguchi A, Iwashima S, Ozaki T, Yasuda K, et al. (2008) Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. Kidney Int 74: 1603-1609.
8. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, et al. (2001) Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease. Circ Res 89: e1-e7.
9. Chiang CH, Huang PH, Chung FP, Chen ZY, Leu HB, et al. (2012) Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoS One 7: e31799.
10. Chiang CH, Huang PH, Chiu CC, Hsu CY, Leu HB, et al. (2014) Reduction of circulating endothelial progenitor cell level is associated with contrast-induced nephropathy in patients undergoing percutaneous coronary and peripheral interventions. PLoS One 9: e89942.
11. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, et al. (2010) Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30: 869-877.
12. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, et al. (2008) Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 197: 496-503.
13. Padfield GJ, Newby DE, Mills NL (2010) Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol 55: 1553-1565.
14. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, et al. (2004) Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 44: 733-739. (Pubitemid 39099565)
15. Marboeuf P, Corseaux D, Mouquet F, Van Belle E, Jude B, et al. (2008) Inflammation triggers colony forming endothelial cell mobilization after angioplasty in chronic lower limb ischemia. J Thromb Haemost 6: 195-197.
16. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967. (Pubitemid 27087709)
17. Banerjee S, Brilakis E, Zhang S, Roesle M, Lindsey J, et al. (2006) Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 189: 70-75. (Pubitemid 44441298)
18. Mills NL, Tura O, Padfield GJ, Millar C, Lang NN, et al. (2009) Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention. Heart 95: 2003-2008.
19. George J, Herz I, Goldstein E, Abashidze S, Deutch V, et al. (2003) Number and adhesive properties of circulating endothelial progenitor cells in patients with instent restenosis. Arterioscler Thromb Vasc Biol 23: e57-60.
20. Matsuo Y, Imanishi T, Hayashi Y, Tomobuchi Y, Kubo T, et al. (2006) The Effect of Senescence of Endothelial Progenitor Cells on In-stent Restenosis in Patients Undergoing Coronary Stenting. Intern Med 45: 581-587. (Pubitemid 43880910)
21. Pelliccia F, Cianfrocca C, Rosano G, Mercuro G, Speciale G, et al. (2010) Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. J Am Coll Cardiol Intv 3: 78-86.
22. Wu CC, Wen SC, Yang CW, Pu SY, Tsai KC, et al. (2009) Plasma ADMA predicts restenosis of arteriovenous fistula. J Am Soc Nephrol 20: 213-222.
23. Rajan DK, Bunston S, Misra S, Pinto R, Lok CE (2004) Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty-are there clinical predictors of patency? Radiology 232: 508-515. (Pubitemid 38971293)
24. Wu C-C, Wen S-C, Yang C-W, Pu S-Y, Tsai K-C, et al. (2010) Baseline plasma glycemic profiles but not inflammatory biomarkers predict symptomatic restenosis after angioplasty of arteriovenous fistulas in patients with hemodialysis. Atherosclerosis 209: 598-600.
25. Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD, et al. (2012) The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 9: 439-453.
26. Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, et al. (2006) Endothelial Dysfunction Contributes to Renal Function-Associated Cardiovascular Mortality in a Population with Mild Renal Insufficiency: The Hoorn Study. J Am Soc Nephrol 17: 537-545.
27. Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, et al. (2005) In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 112: 12-18. (Pubitemid 40962563)
28. Kraan J, Sleijfer S, Foekens JA, Gratama JW (2012) Clinical value of circulating endothelial cell detection in oncology. Drug Discov Today 17: 710-717.
29. Yoder MC (2012) Human endothelial progenitor cells. Cold Spring Harb Perspect Med 2: a006692.
30. Lanuti P, Santilli F, Marchisio M, Pierdomenico L, Vitacolonna E, et al. (2012) A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction. J Immunol Methods 380: 16-22.
31. Kraan J, Strijbos MH, Sieuwerts AM, Foekens JA, den Bakker MA, et al. (2012) A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Haemost 10: 931-939.
32. Nakazawa G, Granada JF, Alviar CL, Tellez A, Kaluza GL, et al. (2010) Anti-CD34 Antibodies Immobilized on the Surface of Sirolimus-Eluting Stents Enhance Stent Endothelialization. J Am Coll Cardiol Intv 3: 68-75.